Canadian Cystic Fibrosis Foundation   Report issue

Foundation Phase 3 Phase 4
Founded: Toronto Canada (1960)

Organization Overview

First Clinical Trial
2007
NCT00528190
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now